ArticleScience advances2024

Tumor-specific delivery of clickable inhibitor for PD-L1 degradation and mitigating resistance of radioimmunotherapy.

Bo Hou et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.